Medica Group PLC Issue of Equity and Total Voting Rights (9167G)
July 30 2021 - 2:00AM
UK Regulatory
TIDMMGP
RNS Number : 9167G
Medica Group PLC
30 July 2021
Medica Group Plc
Issue of Equity and Total Voting Rights
Further to the Block Listing Application announcement on the 5
July 2021, Medica Group PLC (LSE:MGP, " Medica" or the "Company"),
the UK and Ireland market leader in the provision of teleradiology
services, has allotted and issued 36,477 of the 38,076 ordinary
shares of 0.2 pence each in the capital of the Company ("New
Ordinary Shares"). The New Ordinary Shares have been used to
satisfy options under the Company's 2018 Sharesave Scheme. The New
Ordinary Shares will rank pari passu with the Company's existing
shares.
Following Admission of the New Ordinary Shares, the Company have
122,427,237 Ordinary Shares in issue. There are no Ordinary Shares
held in treasury. Therefore, the Company hereby confirms that,
following Admission of the New Ordinary Shares, the total number of
voting rights in the Company are 122,427,237. This figure may be
used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the FCA's Disclosure Guidance and Transparency Rules.
For further information, please contact:
Medica Group Plc:
Dr. Stuart Quin, Chief Executive
Officer
Richard Jones, Chief Financial
Officer +44 (0)33 33 111 222
Investec Bank plc (Joint Broker)
Sara Hale
Daniel Adams
Virginia Bull +44 (0)20 7597 5970
Liberum (Joint Broker)
Bidhi Bhoma
Richard Lindley
Euan Brown +44 (0)20 3100 2000
FTI Consulting
Victoria Foster Mitchell
Sam Purewal +44 (0)20 3727 1000
About Medica Group PLC
Medica is the market leader in the UK and Ireland for the
provision of teleradiology services, providing outsourced
interpretation and reporting of MRI (magnetic resonance imaging),
CT (computerised tomography), ultrasound and plain film (x-ray)
images. Medica also offers diabetic retinopathy screening in
Ireland.
Medica contracts with the largest pool of consultant
radiologists in the UK and Ireland, performing remote access
teleradiology across its customer base of more than 100 NHS Trusts
in the UK, the Irish HSE, private hospital and insurance groups, as
well as diagnostic imaging companies. This enables the Company to
offer a fast, responsive service. In addition, Medica operates in
Australia and New Zealand through MedX, a 50:50 Joint Venture with
Integral Diagnostics Limited Pty.
The Company currently offers two primary services to hospital
radiology departments:
-- NightHawk - urgent reporting service
-- Elective - includes routine cross-sectional reporting on MRI
and CT scans, and routine plain film reporting on x-ray images.
These services are underpinned by Medica's bespoke, secure IT
platform that provides market-leading linkage between a hospital's
Radiology Information System (RIS) and consultant radiologists who
contract with the Company. Direct RIS access ensures that where the
wider patient medical history is available, it can be reviewed by
the consultant as part of every report.
Through its subsidiary, RadMD, in the United States, Medica also
provides pharmaceutical and biotech clients and contract research
organisations (CROs) with high quality, complex imaging services
for international clinical trials. RadMD has gained vast experience
in the space, having contributed to over 500 international clinical
trials, in all phases of clinical research from proof of concept to
phase III and with expertise in oncology, as well as a wider range
of therapeutic areas including medical devices, neurology and
cardiovascular.
For more information please visit: www.medicagroupplc.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEKKLBLFDLZBBQ
(END) Dow Jones Newswires
July 30, 2021 02:00 ET (06:00 GMT)
Medica (LSE:MGP)
Historical Stock Chart
From Apr 2024 to May 2024
Medica (LSE:MGP)
Historical Stock Chart
From May 2023 to May 2024